ZYUS Life Sciences Finalizing Site Initiation for Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug
Article content
Article content
SASKATOON, Saskatchewan — ZYUS Life Sciences Corporation (the 'Company') (TSXV: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce it is in the process of finalizing site initiation for the initial locations to be used in its Phase 2 UTOPIA (Unique Treatment of Oncology Pain in Advanced Cancer) clinical trial.
Article content
The Phase 2 UTOPIA clinical trial will consist of Phase 2A ('UTOPIA-1') and Phase 2B ('UTOPIA-2). UTOPIA-1 is a single-arm proof-of-concept study to investigate the safety and preliminary analgesic efficacy of Trichomylin ® softgel capsules in humans with advanced cancer and moderate to severe cancer-related pain. Insights gained from UTOPIA-1 will guide the strategy for UTOPIA-2, which will be a randomized, placebo-controlled trial that will further assess safety and efficacy in a larger patient population.
Article content
Patient enrollment for UTOPIA-1 is expected to begin in early June 2025, across multiple sites in Canada, with interim data from UTOPIA-1 anticipated mid-summer 2025.
Article content
ZYUS' announcement comes at a time of growing global recognition of the untapped potential of cannabinoids in oncology. A meta-analysis of medial cannabis outcomes and associations with cancer published in Frontiers in Oncology on April 14, 2025, analyzed over 10,000 peer-reviewed studies encompassing 39,767 data points. The findings revealed a 'strong consensus' supporting cannabinoids for managing cancer-related symptoms. While researchers highlight the need for further research to assess the full therapeutic potential of cannabinoids, the findings signal a critical shift in the scientific conversation. This emerging body of evidence reinforces the importance of rigorous clinical research, product purity and consistency, and reinforces ZYUS' commitment to advancing evidence-based cannabinoid therapies.
Article content
'As we finalize site initiation for UTOPIA-1, we are proud to advance clinical development of Trichomylin ® softgel capsules,' said Brent Zettl, President and CEO of ZYUS. 'Our research aims to bridge the gap between conventional treatments like opioids and NSAIDs, and deliver an alternative, evidence-based pharmaceutical option for cancer pain. This trial is a pivotal step in our journey to improve patient outcomes and quality of life.'
Article content
ZYUS (TSXV: ZYUS) is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Through rigorous scientific exploration and clinical research, ZYUS aims to secure intellectual property protection, safeguarding its innovative therapies and bolstering shareholder value. ZYUS' unwavering commitment extends to obtaining regulatory approval of non-opioid-based pharmaceutical solutions, in pursuit of transformational impact on patients' lives. For additional information, visit www.zyus.com or follow us on X @ZYUSCorp.
Article content
This news release contains 'forward-looking information' within the meaning of applicable securities laws relating to the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, use UTOPIA-1 to guide the strategy for UTOPIA-2, begin patient enrollment in June 2025 and obtain interim data respecting UTOPIA-1 by mid-summer 2025. Any such forward-looking statements may be identified by words such as 'expects', 'anticipates', 'intends', 'contemplates', 'believes', 'projects', 'plans', 'will' and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Statements about, among other things, the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates, introduce products that act as alternatives to current pain management therapies such as opioids, use UTOPIA-1 to guide the strategy for UTOPIA-2 begin patient enrollment in June 2025 and obtain interim data respecting UTOPIA-1 by mid-summer 2025 are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the Company will be able to achieve these results. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances or actual results unless required by applicable law.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
For more information, please contact:
Article content
ZYUS Media Inquiries
media@zyus.com
1-833-651-7723
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
an hour ago
- CBC
Four N.L. care homes reach national standard for the first time in provincial first
Four personal care homes are now the first in Newfoundland and Labrador to receive national accreditation for their quality of care. Fort Amherst Healthcare announced that all of the company's four facilities have been recognized by Accreditation Canada after a 2-year process of rigorous assessment to bring their operations to a national standard of care. "What the accreditation process does is it holds up a magnifying glass to every piece of your operating procedure," Forth Amherst Healthcare President Mike Powell said at a press conference in St. John's. Fort Amherst Healthcare's Accreditation Manager Cecilia Penney says it also requires facilities to create better systems to document their work, residents' experiences and manage incident reports. More transparency was one of the many recommendations called for in the Auditor General's scathing report on the state of personal care homes in the province. The report found instances of verbal and sexual abuse allegations, residents going missing and death. Some of these incidents are currently under police investigation. The auditor general also expressed concerns that operational standards haven't been updated since 2007. "We're talking about voluntarily adhering to a higher set of standards than what already exists from a provincial regulation perspective, " Powell said. One of these elevated standards is with incident disclosure. When an incident occurs in a personal care home, staff have a protocol to make family or loved ones aware. "I would say that an accreditation approach goes a little bit deeper and it says, how are you engaging with the people that you're disclosing things to?" Powell said. Penney says the process has also brought benefits to staff satisfaction, leading to the creation of a wellness program to reduce burnout.
National Post
2 hours ago
- National Post
Review: Is the Nanit Pro baby monitor worth it?
Article content Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purchases made through links on this page. Article content When my husband and I first heard about the Nanit Pro baby monitor through a friend, I remember thinking, 'We don't need all that.' Article content Article content After all, we had already dropped thousands of dollars on a crib, bassinet, two Diaper Genies, what I had been assured was the Cadillac of strollers and a virtually indestructible car seat. Did we really need an infant monitor with so many bells and whistles? Article content Article content Fast forward 21 months, and it's one of the first things we suggest to new parents with a little one on the way. Below, I'll take you through what the Nanit Pro offers, how much it'll cost you, what I think some of its best features are, and how it might improve, before sharing my final recommendations. Article content With the Nanit, you can watch and listen in on your child, even when you navigate away from the app, thanks to the background audio and picture-in-picture feature. You can watch multiple kids via a split screen, and the Nanit can even alert you to changes in your child's breathing, if they're standing in the crib, or are somewhere they shouldn't be (like out of bed). Article content Article content It can also capture memories, celebrate milestones and deliver personalized, science-backed insights on your child's sleep and overall development. If your child cries in the middle of the night or tries to get out of the crib, you can play the video back to see exactly what happened and save it on your phone — depending on what subscription you get (but more on that later). Article content Article content The company has been around since 2014 and claims to have the 'largest database of infant sleep and development data' on the market, having clocked more than four billion hours of monitored sleep. The brand also boasts 54 patents and more than 30 developed AI components. Article content While the Nanit website offers everything from monitors, sound machines and breathing wear to apps and subscriptions, you can also opt to keep things simple (and more affordable) with just the camera and stand to monitor your baby via livestream.
CTV News
2 hours ago
- CTV News
Air quality statement issued for Calgary: ECCC
An air quality statement was issued for Calgary Sunday morning. An air quality statement was issued for Calgary Sunday morning as wildfire smoke rolled into the region. Environment and Climate Change Canada (ECCC) posted on its website at 8:06 a.m. that 'wildfire smoke is causing poor air quality and reduced visibility in some areas." It said that conditions were expected to improve later in the day Sunday. The air quality index Sunday at 9:23 a.m. was 7, or 'high-risk.' For more information about wildfire smoke and its impact on your health, go here.
